arjunolic acid has been researched along with malondialdehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manna, P; Sil, PC; Sinha, M | 1 |
| Abdel-Aziz, A; Sarhan, OM; Sherif, IO | 1 |
| Al-Gayyar, MM; Elsherbiny, NM | 1 |
3 other study(ies) available for arjunolic acid and malondialdehyde
| Article | Year |
|---|---|
Protective effect of arjunolic acid against arsenic-induced oxidative stress in mouse brain.
Topics: Animals; Antioxidants; Arsenic; Biphenyl Compounds; Brain; Cell-Free System; Dose-Response Relationship, Drug; Enzymes; Free Radical Scavengers; Hydrazines; Iron; Lipid Peroxidation; Male; Malondialdehyde; Mice; Oxidation-Reduction; Oxidative Stress; Picrates; Protective Agents; Protein Carbonylation; Triterpenes | 2008 |
Cisplatin-induced testicular toxicity in rats: the protective effect of arjunolic acid.
Topics: Animals; Antineoplastic Agents; Cisplatin; Glutathione; Humans; Male; Malondialdehyde; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Sertoli Cells; Testis; Testosterone; Triterpenes; Tumor Necrosis Factor-alpha | 2014 |
Anti-tumor activity of arjunolic acid against Ehrlich Ascites Carcinoma cells in vivo and in vitro through blocking TGF-β type 1 receptor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Ascites; Carcinoma, Ehrlich Tumor; Caspase 3; Cytokines; Female; Inflammation Mediators; Malondialdehyde; Mice; Models, Biological; Oxidative Stress; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta; Triterpenes | 2016 |